IMPEL PHARMACEUTICALS INC: current_liabilities

Value{"amount": 13394000, "concept": "us-gaap:LiabilitiesCurrent", "currency": "USD"}
Period (as of 2021-03-31)
Statuscurrent
EntityIMPEL PHARMACEUTICALS INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000950170-21-000311 · Open the official SEC filing →
Retrieved: 2026-08-19T14:16:28.588953+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001445499/current-liabilities/2021-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/00127d7e-e55b-41b1-9f45-fcf02a2a03e2

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies